CY1106180T1 - Σκευασματα διασπορας τα οποια πepιεχουν αναστολεις λιπασης - Google Patents
Σκευασματα διασπορας τα οποια πepιεχουν αναστολεις λιπασηςInfo
- Publication number
- CY1106180T1 CY1106180T1 CY20061101416T CY061101416T CY1106180T1 CY 1106180 T1 CY1106180 T1 CY 1106180T1 CY 20061101416 T CY20061101416 T CY 20061101416T CY 061101416 T CY061101416 T CY 061101416T CY 1106180 T1 CY1106180 T1 CY 1106180T1
- Authority
- CY
- Cyprus
- Prior art keywords
- inhibitors
- dispersions containing
- containing lipstick
- lipstick
- inhibitor
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 239000006185 dispersion Substances 0.000 title 1
- 229940086609 Lipase inhibitor Drugs 0.000 abstract 1
- 102000019280 Pancreatic lipases Human genes 0.000 abstract 1
- 108050006759 Pancreatic lipases Proteins 0.000 abstract 1
- 239000002270 dispersing agent Substances 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 abstract 1
- 229960001243 orlistat Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Obesity (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Η παρούσα εφεύρεση σχετίζεται με μία φαρμακευτική σύνθεση η οποία περιλαμβάνει τουλάχιστον έναν αναστολέα λιπασών, κατά προτίμηση έναν αναστολέα γαστρεντερικών και παγκρεατικών λιπασών, π.χ. ορλιστάτη, και τουλάχιστον ένα τασιενεργό και τουλάχιστον έναν παράγοντα διασποράς.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99118180 | 1999-09-13 | ||
EP00960643A EP1216025B1 (en) | 1999-09-13 | 2000-09-11 | Dispersion formulations containing lipase inhibitors |
PCT/EP2000/008858 WO2001019340A1 (en) | 1999-09-13 | 2000-09-11 | Dispersion formulations containing lipase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1106180T1 true CY1106180T1 (el) | 2011-06-08 |
Family
ID=8238990
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20061101416T CY1106180T1 (el) | 1999-09-13 | 2006-09-29 | Σκευασματα διασπορας τα οποια πepιεχουν αναστολεις λιπασης |
Country Status (39)
Country | Link |
---|---|
US (3) | US20030181512A1 (el) |
EP (1) | EP1216025B1 (el) |
JP (1) | JP4217016B2 (el) |
KR (1) | KR100572434B1 (el) |
CN (1) | CN1197551C (el) |
AR (1) | AR025587A1 (el) |
AT (1) | ATE333866T1 (el) |
AU (1) | AU769415B2 (el) |
BR (2) | BR0013939A (el) |
CA (1) | CA2383916C (el) |
CO (1) | CO5180587A1 (el) |
CY (1) | CY1106180T1 (el) |
CZ (1) | CZ301901B6 (el) |
DE (1) | DE60029602T2 (el) |
DK (1) | DK1216025T3 (el) |
EG (1) | EG24117A (el) |
ES (1) | ES2267563T3 (el) |
HK (1) | HK1049966A1 (el) |
HR (1) | HRP20020205B1 (el) |
HU (1) | HU228858B1 (el) |
IL (1) | IL148494A0 (el) |
JO (1) | JO2386B1 (el) |
MA (1) | MA26818A1 (el) |
ME (1) | MEP90808A (el) |
MX (1) | MXPA02002034A (el) |
MY (1) | MY130200A (el) |
NO (1) | NO331906B1 (el) |
NZ (1) | NZ517545A (el) |
PE (1) | PE20010595A1 (el) |
PL (1) | PL199870B1 (el) |
PT (1) | PT1216025E (el) |
RS (1) | RS50422B (el) |
RU (1) | RU2239428C2 (el) |
SI (1) | SI1216025T1 (el) |
TR (1) | TR200200606T2 (el) |
TW (1) | TWI243060B (el) |
UY (1) | UY26338A1 (el) |
WO (1) | WO2001019340A1 (el) |
ZA (1) | ZA200201518B (el) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI1307264T1 (en) | 2000-07-28 | 2005-02-28 | F. Hoffmann-La Roche Ag | New pharmaceutical composition |
US20030027786A1 (en) * | 2001-06-06 | 2003-02-06 | Karsten Maeder | Lipase inhibiting composition |
US6730319B2 (en) * | 2001-06-06 | 2004-05-04 | Hoffmann-La Roche Inc. | Pharmaceutical compositions having depressed melting points |
US8372430B2 (en) * | 2002-12-17 | 2013-02-12 | The Procter & Gamble Company | Compositions, methods, and kits useful for the alleviation of gastrointestinal effects |
FI20045076A (fi) * | 2004-03-15 | 2005-09-16 | Bioferme Oy | Funktionaalinen elintarvike |
AU2006236564B2 (en) * | 2005-04-15 | 2011-02-17 | Tolmar, Inc. | Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same |
KR100910000B1 (ko) * | 2005-05-13 | 2009-07-29 | 씨제이제일제당 (주) | 리파아제 저해제 함유 약학 조성물 |
PL1897558T3 (pl) * | 2005-06-09 | 2014-01-31 | Norgine Bv | Stały preparat 2-heksadecyloksy-6-metylo-4H-3,1-benzoksazyn-4-onu |
KR100669497B1 (ko) * | 2005-08-17 | 2007-01-16 | 보람제약주식회사 | 안정성과 용출률이 뛰어난 약리학적 조성물 및 그 제조방법 |
WO2007033522A1 (fr) * | 2005-09-21 | 2007-03-29 | Shenzhen Tys R & D Co., Ltd. | Formulation de gélule contenant de la moxifloxacine et son procédé de préparation |
KR101252635B1 (ko) * | 2006-04-20 | 2013-04-10 | (주)아모레퍼시픽 | 리파아제 저해제 및 친유성 오일흡수제를 포함하는 약학조성물 및 이로부터 제조된 경구 투여용 제제 |
TR200607613A2 (tr) * | 2006-12-29 | 2008-07-21 | NOBEL İLAÇ SAN.ve TiC.A.Ş. | Lipaz inhibitörü içeren farmasötik formülasyonlar |
EP1970051A1 (en) * | 2007-03-14 | 2008-09-17 | Merz Pharma GmbH & Co.KGaA | Use of an aqueous micro-emulsion for the preparation of a formulation for the treatment of adipose diseases |
KR101439470B1 (ko) * | 2007-05-22 | 2014-09-16 | 한미사이언스 주식회사 | 오를리스타트 및 대변 연화제를 포함하는 비만의 예방 또는치료용 조성물 |
PL2036575T3 (pl) * | 2007-09-12 | 2011-02-28 | Mader S R L | Kompozycje farmaceutyczne do stosowania doustnie w leczeniu pacjentów dotkniętych otyłością |
EP2044930A1 (en) * | 2007-10-01 | 2009-04-08 | Nestec S.A. | Composition for controlling lipase catalyzed reactions |
PL216542B1 (pl) | 2008-03-20 | 2014-04-30 | Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna | Sposób wytwarzania stabilnej kompozycji orlistatu w postaci kapsułkowanego proszku |
WO2010042499A1 (en) * | 2008-10-06 | 2010-04-15 | Banner Pharmacaps, Inc. | Stable solutions of orlistat for pharmaceutical dosage forms |
KR20100075260A (ko) * | 2008-12-24 | 2010-07-02 | 주식회사종근당 | 리파아제 저해제의 부작용 개선을 위한 신규한 약제학적 조성물 |
BRPI0901602B8 (pt) | 2009-04-03 | 2021-05-25 | Ems S/A | formulação farmacêuticas |
ITRM20120331A1 (it) | 2012-07-12 | 2014-01-13 | Guidotti & C Spa Labor | Composizioni pediatriche orali liquide contenenti nepadutant. |
WO2016166767A1 (en) * | 2015-04-14 | 2016-10-20 | Zim Laboratories Limited | Pharmaceutical formulation comprising low melting, highly lipophilic drugs |
CN106310287B (zh) * | 2015-06-25 | 2019-03-19 | 山东省药学科学院 | 新利司他药用组合物及其制备方法 |
MY196635A (en) * | 2018-06-22 | 2023-04-25 | Sime Darby Plantation Intellectual Property Sdn Bhd | Method For Reducing Formation of Free Fatty Acids in Plants |
CN115105476B (zh) * | 2021-03-23 | 2023-11-14 | 山东新时代药业有限公司 | 一种奥利司他冻干口服制剂及其制备工艺 |
CN114983938A (zh) * | 2022-05-19 | 2022-09-02 | 广东嘉博制药有限公司 | 一种奥利司他口服复合乳液及其制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1247547A (en) | 1983-06-22 | 1988-12-28 | Paul Hadvary | Leucine derivatives |
DE3887179T2 (de) * | 1987-03-02 | 1994-06-16 | Brocades Pharma Bv | Pharmazeutische Zusammensetzung, pharmazeutisches Granulat und Verfahren zu ihrer Herstellung. |
TW381025B (en) | 1993-08-05 | 2000-02-01 | Hoffmann La Roche | Pharmaceutical composition containing a glucosidase inhibitor and a lipase inhibitor |
IT1282673B1 (it) | 1996-02-23 | 1998-03-31 | Ist Naz Stud Cura Dei Tumori | Derivati della camptotecina e loro uso come agenti antitumorali |
EP1017366A4 (en) | 1996-09-01 | 2006-03-22 | Pharmos Corp | SOLID COPARCIPITATES FOR IMPROVED BIOVERABILITY OF LIPOPHILIC SUBSTANCES |
US5891469A (en) * | 1997-04-02 | 1999-04-06 | Pharmos Corporation | Solid Coprecipitates for enhanced bioavailability of lipophilic substances |
US6004996A (en) * | 1997-02-05 | 1999-12-21 | Hoffman-La Roche Inc. | Tetrahydrolipstatin containing compositions |
DK1017408T3 (da) * | 1997-02-05 | 2005-08-01 | Hoffmann La Roche | Anvendelse af tetrahydrolipstatin i behandling af diabetes type II |
US6267952B1 (en) | 1998-01-09 | 2001-07-31 | Geltex Pharmaceuticals, Inc. | Lipase inhibiting polymers |
DK1105122T3 (da) | 1998-08-14 | 2005-08-08 | Hoffmann La Roche | Pharmaceutical compositions containing lipase inhibitors |
ES2217797T3 (es) | 1998-08-14 | 2004-11-01 | F. Hoffmann-La Roche Ag | Vinileteres heterociclicos contra trastornos neurologicos. |
US6368622B2 (en) * | 1999-01-29 | 2002-04-09 | Abbott Laboratories | Process for preparing solid formulations of lipid regulating agents with enhanced dissolution and absorption |
-
2000
- 2000-09-07 AR ARP000104679A patent/AR025587A1/es not_active Application Discontinuation
- 2000-09-11 TR TR2002/00606T patent/TR200200606T2/xx unknown
- 2000-09-11 EP EP00960643A patent/EP1216025B1/en not_active Expired - Lifetime
- 2000-09-11 IL IL14849400A patent/IL148494A0/xx active IP Right Grant
- 2000-09-11 WO PCT/EP2000/008858 patent/WO2001019340A1/en active IP Right Grant
- 2000-09-11 CA CA002383916A patent/CA2383916C/en not_active Expired - Lifetime
- 2000-09-11 PL PL356174A patent/PL199870B1/pl unknown
- 2000-09-11 CN CNB008126801A patent/CN1197551C/zh not_active Expired - Lifetime
- 2000-09-11 ES ES00960643T patent/ES2267563T3/es not_active Expired - Lifetime
- 2000-09-11 PT PT00960643T patent/PT1216025E/pt unknown
- 2000-09-11 DE DE60029602T patent/DE60029602T2/de not_active Expired - Lifetime
- 2000-09-11 BR BR0013939-4A patent/BR0013939A/pt not_active IP Right Cessation
- 2000-09-11 CZ CZ20021276A patent/CZ301901B6/cs not_active IP Right Cessation
- 2000-09-11 RS YUP-172/02A patent/RS50422B/sr unknown
- 2000-09-11 BR BRPI0013939-4A patent/BRPI0013939B1/pt unknown
- 2000-09-11 MX MXPA02002034A patent/MXPA02002034A/es active IP Right Grant
- 2000-09-11 AU AU72863/00A patent/AU769415B2/en not_active Expired
- 2000-09-11 SI SI200030888T patent/SI1216025T1/sl unknown
- 2000-09-11 JP JP2001522975A patent/JP4217016B2/ja not_active Expired - Lifetime
- 2000-09-11 NZ NZ517545A patent/NZ517545A/en not_active IP Right Cessation
- 2000-09-11 DK DK00960643T patent/DK1216025T3/da active
- 2000-09-11 ME MEP-908/08A patent/MEP90808A/xx unknown
- 2000-09-11 HU HU0202737A patent/HU228858B1/hu unknown
- 2000-09-11 AT AT00960643T patent/ATE333866T1/de active
- 2000-09-11 KR KR1020027003269A patent/KR100572434B1/ko active IP Right Grant
- 2000-09-11 RU RU2002107428/15A patent/RU2239428C2/ru active
- 2000-09-12 EG EG20001159A patent/EG24117A/xx active
- 2000-09-12 UY UY26338A patent/UY26338A1/es not_active Application Discontinuation
- 2000-09-12 JO JO2000157A patent/JO2386B1/en active
- 2000-09-12 CO CO00068859A patent/CO5180587A1/es active IP Right Grant
- 2000-09-13 MY MYPI20004253A patent/MY130200A/en unknown
- 2000-09-13 PE PE2000000949A patent/PE20010595A1/es not_active IP Right Cessation
- 2000-10-19 TW TW089121968A patent/TWI243060B/zh not_active IP Right Cessation
-
2002
- 2002-02-22 ZA ZA200201518A patent/ZA200201518B/xx unknown
- 2002-03-07 HR HR20020205A patent/HRP20020205B1/xx not_active IP Right Cessation
- 2002-03-11 MA MA26545A patent/MA26818A1/fr unknown
- 2002-03-12 NO NO20021204A patent/NO331906B1/no not_active IP Right Cessation
-
2003
- 2003-03-25 HK HK03102148A patent/HK1049966A1/xx not_active IP Right Cessation
- 2003-04-21 US US10/419,346 patent/US20030181512A1/en not_active Abandoned
-
2004
- 2004-03-05 US US10/794,123 patent/US8012494B2/en not_active Expired - Lifetime
-
2006
- 2006-09-29 CY CY20061101416T patent/CY1106180T1/el unknown
-
2011
- 2011-07-19 US US13/185,558 patent/US20110275706A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1106180T1 (el) | Σκευασματα διασπορας τα οποια πepιεχουν αναστολεις λιπασης | |
BG104780A (en) | Inhibitors of phospholipase enzymes | |
TR200101858T2 (tr) | JNK protein kinaz inhibitörleri olarak 4-ariloksindoller | |
TR200103216T2 (tr) | Pirimidinon bileşimleri | |
CY1105538T1 (el) | Ιατρικη μορφοποιηση αερολυματος | |
DK0960107T3 (da) | 6-Thiosubstituerede paclitaxeler | |
CY1105009T1 (el) | Συνθεση καχαλαλιδης f | |
DK0639577T3 (da) | Phosphonooxymethyl- eller methylthiomethylestere af taxanderivater som antitumormidler | |
IS6997A (is) | Lyfjafræðilega virkir úridín esterar | |
TR199800773T2 (xx) | Trombin inhibit�rleri. | |
DE60019100D1 (de) | Im wesentlichen ölfreie cyclosporin zusammensetzungen | |
TR200101756T2 (tr) | Protein kinaz inhibitörleri olarak 4,5-pirazinoksindoller. | |
PT1282418E (pt) | Utilizacao de derivados pirazolo para o tratamento da infertilidade | |
ATE242630T1 (de) | Beladene bakterienghosts als träger- und targetingvehikel | |
DE60025392D1 (de) | Behälter für feuchtigkeitstücher | |
DK1198225T3 (da) | Epothilonsammensætninger | |
DE69829963D1 (de) | Zusammensetzungen und verfahren zur behinderung der entladung von nematokyste | |
HUP0300730A2 (hu) | Eljárás instabil angina pectoris kezelésére | |
ATE305517T1 (de) | Neurotrypsin | |
ATE315629T1 (de) | Bleichmittelzusammensetzungen | |
DK1011329T3 (da) | 7-Methylthiooxomethyl- og 7-methylthiodioxomethyl-paclitaxeler | |
FR2783518B1 (fr) | Inhibiteurs de lta4 hydrolase | |
ATE272125T1 (de) | Enzymatisch katalysierte signalamplifizierung | |
ECSP972266A (es) | Terapia de combinacion para el tratamiento de psicosis | |
ES2196503T3 (es) | Procedimientos e intermedios para la preparacion de pirrolo(3,2-b)piridinas. |